Active — Not RecruitingNot Applicable

Sensitivity to Acute Cerebral Ischemia in Migrainers

France605 participantsStarted 2018-02-09

Plain-language summary

Sensitivity to Acute Middle cerebral or intracranial Carotid artery Occlusion in MIGrainers (SMCO-MIG) is a prospective multi-center study to determine if migraine induces a faster infarct growth as assessed by initial multimodal imaging.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Males and females, 18 to 75 years old * Admitted to a stroke unit for an acute ischemic stroke (\<12 h) * Angiography showing M1/M2 or intracranial internal carotid artery occlusion * MRI or CT acquired \<24h from IS onset, using a harmonized protocol enabling calculation of the mismatch Exclusion Criteria: * Individual enrolled into another study protocol with a period of exclusion still running at potential inclusion * Coma, dementia, linguistic problem or aphasia preventing responding to the migraine questionnaire * Refusal of participation * Persons under legal protection, guardianship or curatorship

What they're measuring

Mismatch ratio (MRI DWI/PWI or CT rCBF/CTP)

Timeframe: 24 hours

Trial details

NCT IDNCT03301441

SponsorUniversity Hospital, Montpellier

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-03-06

View on ClinicalTrials.gov More Ischemic Stroke trials